News on Tesia-PCI Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Tesia-PCI Corporation news from BioPortfolio.com Wed, 10 Feb 2010 11:18:46 GMT en SMT Research And Development, Ltd. Reports Two Successful Clinical Caseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040874&HITNO=0&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040874&THISHREF=http://c.moreover.com/click/here.pl%3fz2538908860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040874&HITNO=0&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040874&THISHREF=http://c.moreover.com/click/here.pl%3fz2538908860%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: SMT Research and Development completes first two clinical cases using Shimon Embolic Filterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040594&HITNO=1&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040594&THISHREF=http://c.moreover.com/click/here.pl%3fz2538801825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040594&HITNO=1&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040594&THISHREF=http://c.moreover.com/click/here.pl%3fz2538801825%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: SMT Research and Development, Ltd. Reports Two Successful Clinical Caseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038521&HITNO=2&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038521&THISHREF=http://c.moreover.com/click/here.pl%3fz2537643574%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038521&HITNO=2&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038521&THISHREF=http://c.moreover.com/click/here.pl%3fz2537643574%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032876&HITNO=3&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032876&THISHREF=http://c.moreover.com/click/here.pl%3fz2534845665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032876&HITNO=3&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032876&THISHREF=http://c.moreover.com/click/here.pl%3fz2534845665%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Acute Coronary Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027474&HITNO=4&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027474&THISHREF=http://c.moreover.com/click/here.pl%3fz2532205652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027474&HITNO=4&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027474&THISHREF=http://c.moreover.com/click/here.pl%3fz2532205652%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRLog: Life Sciences: New findings from University of Glasgow, Glasgow Cardiovascular Research Center describe advances in life scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026192&HITNO=5&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026192&THISHREF=http://c.moreover.com/click/here.pl%3fz2530490992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026192&HITNO=5&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026192&THISHREF=http://c.moreover.com/click/here.pl%3fz2530490992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Europe, North America Gaining CTO Experience But Attempt Rates Still Lowhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024664&HITNO=6&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024664&THISHREF=http://c.moreover.com/click/here.pl%3fz2529049885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024664&HITNO=6&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024664&THISHREF=http://c.moreover.com/click/here.pl%3fz2529049885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTCTMD.com: PCI chairman justifies Council's non-recognition of MS programmehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024445&HITNO=7&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024445&THISHREF=http://c.moreover.com/click/here.pl%3fz2528896470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024445&HITNO=7&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024445&THISHREF=http://c.moreover.com/click/here.pl%3fz2528896470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: This week at Open Medicine - new researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020624&HITNO=8&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020624&THISHREF=http://c.moreover.com/click/here.pl%3fz2526891885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020624&HITNO=8&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020624&THISHREF=http://c.moreover.com/click/here.pl%3fz2526891885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOpen Medicine: Warning on treating MI with long-term clopidogrelhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020171&HITNO=9&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020171&THISHREF=http://c.moreover.com/click/here.pl%3fz2526626764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020171&HITNO=9&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020171&THISHREF=http://c.moreover.com/click/here.pl%3fz2526626764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPulse: Euthymics Bioscience Collaborates with GlobalSign and SafeNet to provide an FDA approved Electronic Signaturehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019574&HITNO=10&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019574&THISHREF=http://c.moreover.com/click/here.pl%3fz2526377087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019574&HITNO=10&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019574&THISHREF=http://c.moreover.com/click/here.pl%3fz2526377087%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTechWhack: 2/4/10 - Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018002&HITNO=11&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018002&THISHREF=http://c.moreover.com/click/here.pl%3fz2525418151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018002&HITNO=11&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018002&THISHREF=http://c.moreover.com/click/here.pl%3fz2525418151%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: In diabetics, revascularization more likely after PCI vs CABGhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009731&HITNO=12&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009731&THISHREF=http://c.moreover.com/click/here.pl%3fz2522067330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009731&HITNO=12&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009731&THISHREF=http://c.moreover.com/click/here.pl%3fz2522067330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: Meta-Analysis: Thrombectomy Improves Reperfusion But Not Clinical Outcome in STEMIhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009884&HITNO=13&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009884&THISHREF=http://c.moreover.com/click/here.pl%3fz2522136964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4009884&HITNO=13&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4009884&THISHREF=http://c.moreover.com/click/here.pl%3fz2522136964%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTCTMD.com: Cardiogenic Shock: From Reperfusion to Revascularization and Hemodynamic Supporthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011247&HITNO=14&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011247&THISHREF=http://c.moreover.com/click/here.pl%3fz2522844216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011247&HITNO=14&MSIZE=207&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tesia-PCI%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011247&THISHREF=http://c.moreover.com/click/here.pl%3fz2522844216%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comVascular Disease Management: